by Lisa Gurry, Chief Growth Officer | Jan 31, 2023 | News
Last week, I joined a few of my fellow Truvetans, including our CEO Terry Myerson, pictured above, at the Precision Medicine World Conference in Santa Clara, CA for a few days of meetings, sessions, and great discussions. I personally find it so valuable to connect...
by Truveta Research | Jan 20, 2023 | Research, Research Insights
On January 2, 2023 during NFL Monday Night Football, Buffalo Bills safety Damar Hamlin collapsed on the football field after an un-noteworthy tackle, shocking and saddening NFL players and fans around the world (Broaddus et al., 2023). In the days that followed, we...
by Truveta Staff | Jan 18, 2023 | News, Research
In November, Truveta Research shared their findings on racial disparities in treatment and hospitalization during different periods of time of the COVID-19 pandemic. Now, the peer-reviewed paper, “Racial inequality in COVID treatment and in-hospital length of...
by Truveta Research | Jan 13, 2023 | Research, Research Insights
Intended for a scientific audience, Truveta Research Technical Reports are a new way of looking at the timely, representative, and de-identified data in Truveta Studio. The Truveta Research blog will surface insights shown in these Technical Reports for a broader...
by Truveta Staff | Jan 10, 2023 | Technology
The key to any disease study is rich data. We recently met with the CEO of a biotech company that specializes in the development of immunotherapies. He and his team had tried to recruit patients for a series of clinical trials related to several rare disease...
